Influence of several drugs on the in vivo and in vitro activity of mammalian hepatic azo-reductase.
D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D009582:Nitrofurantoin / Q000494:pharmacology; D010088:Oxidoreductases / Q000378:metabolism*; D010433:Pentylenetetrazole / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013442:Sulfinpyrazone / Q000494:pharmacology; D013451:Sulfonic Acids / Q000652:urine; D014293:Trimethadione / Q000494:pharmacology
D013451:Sulfonic Acids; D002110:Caffeine; D010672:Phenytoin; D009582:Nitrofurantoin; D007490:Iproniazid; D010088:Oxidoreductases; D010653:Phenylbutazone; D014293:Trimethadione; D013442:Sulfinpyrazone; D007538:Isoniazid; D010433:Pentylenetetrazole; D010634:Phenobarbital; D006145:Guanethidine